ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Investors including co-founder and Harvard professor Timothy Springer scored exits as mRNA therapy developer Moderna floated in the largest biotech IPO of all time.
10X Genomics has purchased genomic analysis platform Spatial Transcriptomics, based on research at Karolinska Institute and KTH Royal Institute of Technology.
Ireland’s Comptroller and Auditor General has highlighted issues in a Waterford Institute of Technology licensing deal that garnered low returns when the spinout in question was acquired.
Synthorx, spun out of Scripps Research Institute, is targeting $100m in a proposed offering half a year after it raised $63m in a series C round backed by Osage University Partners.
The biopharmaceutical spinout of University of Veterinary Medicine Vienna is issuing 400,000 shares in an initial public offering that is set to fetch between $34m and $41m.